NOX 4.17% 6.9¢ noxopharm limited

Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-19

  1. 1,610 Posts.
    lightbulb Created with Sketch. 409
    But in this case the mice carried human tumours - the drug effect was not on the mice, it was on the tumours. I think that is an important distinction.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.